Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-189.33%Return on Invested Capital
VS
Market
Sector
Industry
History
$ 1.83Close
$ 1.76 - $ 10.48 52-Week Range
Ticker Information
Ticker
INMBCompany Name
INMUNE BIO INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQINMUNE BIO INC - Return on Invested Capital Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
INMB - ROIC Historical data
| Date | Invested Capital | Net Income Common Stock | Return on Invested Capital |
|---|---|---|---|
| 6/30/2025 | $ 29.32M | $ -55.51M | -189.33% |
| 3/31/2025 | $ 30.02M | $ -40.8M | -135.9% |
| 12/31/2024 | $ 32.48M | $ -42.08M | -129.56% |
| 9/30/2024 | $ 41.59M | $ -41.27M | -99.24% |
| 6/30/2024 | $ 41.71M | $ -37.74M | -90.48% |
| 3/31/2024 | $ 36.16M | $ -34.5M | -95.39% |
| 12/31/2023 | $ 47.78M | $ -30.01M | -62.81% |
| 9/30/2023 | $ 56.84M | $ -27.43M | -48.26% |
| 6/30/2023 | $ 66.04M | $ -26.59M | -40.27% |
| 3/31/2023 | $ 70.66M | $ -26.93M | -38.11% |
Key Performance Insights, Last 5 Years
- INMUNE BIO INC's latest trailing twelve months (TTM) ROIC stands at -27.11%.
- Over the past 5 years, INMUNE BIO INC's average ROIC has been -62.43%.
- The median ROIC for INMUNE BIO INC during this period was -38.96%
- INMUNE BIO INC reached its highest ROIC over the past 5 years at -22.9%.
- The lowest ROIC recorded by INMUNE BIO INC in the same timeframe -189.33%
INMUNE BIO INC's ROIC vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROIC Benchmarks
Similar metrics to ROIC:
- Cash Return on Invested Capital - [Calculation] Cash Return on Invested Capital (CROIC) measures how well a company uses its invested capital to produce cash. It is calculated as Free Cash Flow [FCF] divided by invested capital [InvCapital].
- Invested Capital - [Calculation] Invested Capital is the total amount of money raised by a business in the form [Equity] and/or [Debt].
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Capital Expenditures to Operating Cash Flow - [Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
Definition of Return on Invested Capital
[Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].Net Inc. Cmn. / Inv. Capital
(=) ROIC ROIC for INMUNE BIO INC is calculated as follows: Net Inc. Cmn. [ $ -11.21M ] / Inv. Capital [ $ 41.36M ]
(=) ROIC [ -27.11% ] INMB - Return on Invested Capital, Last 5 years
-189.33%
Minimum
Jun 30, 2025
-22.9%
Maximum
Mar 31, 2021
-62.43%
Average
-38.96%
Median
ROIC Benchmark AnalysisMarket
The chart above depicts the distribution of ROIC for companies in the Total Stock Market. The average ROIC of the companies is 0.68% with a standard deviation of 15.2%.
The following table provides additional summary stats:
ROIC in the Market:
| filtered constituents | 3.36K |
|---|---|
| min | -46.36% |
| max | 48.66% |
| average | 0.68% |
| median | 3.38% |
| std | 15.2% |